A PROSPECTIVE, RANDOMIZED EVALUATION OF THE EFFECT OF SILVER IMPREGNATED SUBCUTANEOUS CUFFS FOR PREVENTING TUNNELED CHRONIC VENOUS ACCESS CATHETER INFECTIONS IN CANCER-PATIENTS
Js. Groeger et al., A PROSPECTIVE, RANDOMIZED EVALUATION OF THE EFFECT OF SILVER IMPREGNATED SUBCUTANEOUS CUFFS FOR PREVENTING TUNNELED CHRONIC VENOUS ACCESS CATHETER INFECTIONS IN CANCER-PATIENTS, Annals of surgery, 218(2), 1993, pp. 206-210
Objective This study was performed to evaluate the effect of a silver
impregnated cuff on the incidence of catheter related bacteremia/funge
mia or tunnel tract infection in cancer patients with chronic dual-lum
en tunneled venous access catheters Summary Background Data Infection
is a frequent and potentially life threatening complication of tunnele
d chronic cuffed silastic central venous access catheters in cancer pa
tients. Recent experience with antimicrobial silver-impregnated cuffs
placed on nontunneled percutaneously inserted central venous catheters
suggests that such a cuff may render the catheter less prone to infec
tion. Methods The authors prospectively randomized 200 cancer patients
to receive either a dual-lumen 10 French tunneled cuffed silastic cen
tral venous access catheter or the same catheter with a second more pr
oximal subcutaneous silver impregnated cuff. All patients then were fo
llowed prospectively for infectious morbidity until the device was rem
oved or the patient died. Results The hazard rate for infection/day (9
5% confidence limits) was 0.0022 (0.0015 to 0.0030) for standard cathe
ters compared with 0.0027 (0.0019 to 0.0037) tor catheters with silver
-impregnated cuffs (p = not significant). Regression analysis of infec
tion-free interval of both catheter types shows no difference over the
lifetime of catheter as well as the over the first 48 days after inse
rtion, Conclusions The study indicated no effect of a silver-impregnat
ed cuff in decreasing the incidence of catheter related bacteremias/fu
ngemias, tunnel infections, or the spectrum of causative microorganism
s involved in cancer patients with tunneled chronic venous access cath
eters.